270 related articles for article (PubMed ID: 30632128)
1. Mechanisms and Treatment for Cancer- and Chemotherapy-Related Cognitive Impairment in Survivors of Non-CNS Malignancies.
Chung NC; Walker AK; Dhillon HM; Vardy JL
Oncology (Williston Park); 2018 Dec; 32(12):591-8. PubMed ID: 30632128
[TBL] [Abstract][Full Text] [Related]
2. A Call for a Neuroscience Approach to Cancer-Related Cognitive Impairment.
Horowitz TS; Suls J; Treviño M
Trends Neurosci; 2018 Aug; 41(8):493-496. PubMed ID: 29907436
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-related cognitive impairment: mechanisms, clinical features and research perspectives.
Cascella M; Di Napoli R; Carbone D; Cuomo GF; Bimonte S; Muzio MR
Recenti Prog Med; 2018 Nov; 109(11):523-530. PubMed ID: 30565571
[TBL] [Abstract][Full Text] [Related]
4. What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.
Williams AM; Zent CS; Janelsins MC
Br J Haematol; 2016 Sep; 174(6):835-46. PubMed ID: 27391367
[TBL] [Abstract][Full Text] [Related]
5. Cognitive Changes Related to Cancer Therapy.
Vannorsdall TD
Med Clin North Am; 2017 Nov; 101(6):1115-1134. PubMed ID: 28992858
[TBL] [Abstract][Full Text] [Related]
6. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-related cognitive impairment in older patients with cancer.
Loh KP; Janelsins MC; Mohile SG; Holmes HM; Hsu T; Inouye SK; Karuturi MS; Kimmick GG; Lichtman SM; Magnuson A; Whitehead MI; Wong ML; Ahles TA
J Geriatr Oncol; 2016 Jul; 7(4):270-80. PubMed ID: 27197918
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy.
Cerulla Torrente N; Navarro Pastor JB; de la Osa Chaparro N
J Cancer Surviv; 2020 Aug; 14(4):464-482. PubMed ID: 32146576
[TBL] [Abstract][Full Text] [Related]
9. Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: protocol for a scoping review.
Mayo SJ; Kuruvilla J; Laister RC; Ayala AP; Alm M; Byker W; Kelly DL; Saligan L
BMJ Open; 2018 Jan; 8(1):e017578. PubMed ID: 29374660
[TBL] [Abstract][Full Text] [Related]
10. The Experience of Cancer-Related Cognitive Impairment Across Common Cancers: Protocol for a Qualitative Systematic Review.
Ibrar M; Rai HK; Main A; McCartney H; Maguire R; Rodriguez MAP
JMIR Res Protoc; 2024 May; 13():e56888. PubMed ID: 38820581
[TBL] [Abstract][Full Text] [Related]
11. Self-reported cognitive outcomes among adolescent and young adult patients with noncentral nervous system cancers.
Tan CJ; Mah JJJ; Goh WL; Poon E; Harunal Rashid MF; Chan A
Psychooncology; 2020 Aug; 29(8):1355-1362. PubMed ID: 32597001
[TBL] [Abstract][Full Text] [Related]
12. Cancer-related cognitive impairment in survivors of adolescent and young adult non-central nervous system cancer: A scoping review.
Vizer LM; Mikles SP; Piepmeier AT
Psychooncology; 2022 Aug; 31(8):1275-1285. PubMed ID: 35726379
[TBL] [Abstract][Full Text] [Related]
13. Computer-Based Cognitive Training for Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors.
Bail J; Meneses K
Clin J Oncol Nurs; 2016 Oct; 20(5):504-9. PubMed ID: 27668370
[TBL] [Abstract][Full Text] [Related]
14. Effects of Acupuncture on Cancer-Related Cognitive Impairment in Chinese Gynecological Cancer Patients: A Pilot Cohort Study.
Zeng Y; Cheng ASK; Song T; Sheng X; Wang S; Xie J; Chan CCH
Integr Cancer Ther; 2018 Sep; 17(3):737-746. PubMed ID: 29806502
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.
Wefel JS; Kesler SR; Noll KR; Schagen SB
CA Cancer J Clin; 2015 Mar; 65(2):123-38. PubMed ID: 25483452
[TBL] [Abstract][Full Text] [Related]
16. Cognitive Changes in Cancer Survivors.
Hardy SJ; Krull KR; Wefel JS; Janelsins M
Am Soc Clin Oncol Educ Book; 2018 May; 38():795-806. PubMed ID: 30231372
[TBL] [Abstract][Full Text] [Related]
17. Cancer-related cognitive impairment: a mixed methods evaluation of a standard factsheet.
Lim CYS; He S; Shaw J; Dhillon HM
Support Care Cancer; 2022 Mar; 30(3):2375-2385. PubMed ID: 34741655
[TBL] [Abstract][Full Text] [Related]
18. Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group.
Mayo SJ; Lustberg M; M Dhillon H; Nakamura ZM; Allen DH; Von Ah D; C Janelsins M; Chan A; Olson K; Tan CJ; Toh YL; Oh J; Grech L; Cheung YT; Subbiah IM; Petranovic D; D'Olimpio J; Gobbo M; Koeppen S; Loprinzi CL; Pang L; Shinde S; Ntukidem O; Peters KB
Support Care Cancer; 2021 Jun; 29(6):2821-2840. PubMed ID: 33231809
[TBL] [Abstract][Full Text] [Related]
19. Australian oncology health professionals' knowledge, perceptions, and clinical practice related to cancer-related cognitive impairment and utility of a factsheet.
He S; Lim CYS; Dhillon HM; Shaw J
Support Care Cancer; 2022 Jun; 30(6):4729-4738. PubMed ID: 35122530
[TBL] [Abstract][Full Text] [Related]
20. Cognitive changes associated with cancer and cancer treatment: state of the science.
Von Ah D
Clin J Oncol Nurs; 2015 Feb; 19(1):47-56. PubMed ID: 25689649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
